Combined Atrial Fibrillation Ablation and Renal Artery Denervation for the Maintenance of Sinus Rhythm and Management of Resistant Hypertension
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- change in systolic blood pressure when measured at routine 1 and 3 month follow up appointments
研究概览
简要总结
The purpose of this study is to perform renal artery denervation at the same time as atrial fibrillation ablation. RA denervation may reduce blood pressure, increase the chances of a successful atrial fibrillation ablation, and decrease the number of medications required to control blood pressure.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 100 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hypertensive patients scheduled for afib ablation
- •Patient taking one or more BP medication
排除标准
- 未提供
研究组 & 干预措施
Combined afib ablation and RA denervation
Patients with atrial fibrillation and resistant hypertension will be enrolled and undergo a single procedure consisting of pulmonary vein isolation and renal artery denervation.
干预措施: Renal Artery denervation (Procedure)
结局指标
主要结局
change in systolic blood pressure when measured at routine 1 and 3 month follow up appointments
时间窗: 1 to 3 months
次要结局
未报告次要终点
研究者
Charles Henrikson, MD
Associate Professor, Knight Cardiovascular Institute
Oregon Health and Science University
